Telesis Bio Inc (TBIO)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
CEO:
Todd R. Nelson
Employees:
210
9535 WAPLES STREET, SUITE 100, SAN DIEGO, CA, 92121
858-228-4115

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA.

Data derived from most recent annual or quarterly report
Market Cap 81.48 Million Shares Outstanding29.522 Million Avg 30-day Volume 491.105 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.42
Price to Revenue2.3285 Debt to Equity0.3652 EBITDA-47.801 Million
Price to Book Value0.9192 Operating Margin-240.91429999999997 Enterprise Value18.541 Million
Current Ratio4.855 EPS Growth0 Quick Ratio4.327
1 Yr BETA 1.4177 52-week High/Low 6.5 / 1.08 Profit Margin-251.0454
Operating Cash Flow Growth-57.9395 Altman Z-Score-1.8228 Free Cash Flow to Firm 0
Earnings Report2023-05-09

Are you looking for these stocks instead?

View recent insider trading info

Funds Holding TBIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TBIO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NELSON TODD ROBERT PRESIDENT & CEO

  • Officer
  • Director
  • 10% Owner
6,213,263 2022-11-11 1

GIBSON DANIEL GLENN CHIEF TECHNOLOGY OFFICER

  • Officer
100,000 2022-08-04 1

HUNTER BRENT M. VICE PRESIDENT, FINANCE & PFO

  • Officer
125,000 2022-08-04 2

ESSER ERIC EUGENE CHIEF OPERATING OFFICER

  • Officer
50,000 2022-08-04 3

TUMOLO ANNETTE

  • Director
186,528 2022-07-20 2

NACHTSHEIM JAMI K

  • Director
51,575 2022-06-09 1

TSINGOS CHRISTINE A

  • Director
51,575 2022-06-09 1

SNIDER WILLIAM

  • Director
  • 10% Owner
2,370,620 2022-06-09 1

WITNEY FRANK

  • Director
51,575 2022-06-09 1

JACKSON ANDREA LIAPIS

  • Director
51,575 2022-06-09 2

MCNEALEY JENNIFER ISACOFF CHIEF FINANCIAL OFFICER

  • Officer
135,300 2022-02-27 0

BAUPOST GROUP LLC/MA

BAUPOST GROUP GP, L.L.C.

KLARMAN SETH A

  • 10% Owner
0 2021-09-14 0

FORMELA JEAN FRANCOIS

  • Director
0 2021-09-14 0

RENAUD RONALD C JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-09-14 0

DANAHER CORP /DE/

DANAHER INNOVATION CENTER LLC

  • 10% Owner
No longer subject to file 2021-06-22 0

BROADOAK FUND IV, LLC

  • 10% Owner
No longer subject to file 2021-06-22 0

NORTHPOND VENTURES GP, LLC

NORTHPOND VENTURES, LP

NORTHPOND VENTURES GP II, LLC

NORTHPOND VENTURES II, LP

RUBIN MICHAEL P.

  • 10% Owner
9,844,130 2021-06-22 0

GATTACA MINING LLC

  • 10% Owner
6,000,000 2021-06-22 0

NORTHPOND VENTURES GP II, LLC

NORTHPOND VENTURES II, LP

  • 10% Owner
468,750 2021-06-22 0

NORTHPOND VENTURES GP, LLC

NORTHPOND VENTURES, LP

RUBIN MICHAEL P.

  • 10% Owner
0 2021-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TELESIS BIO INC TBIO 2023-03-28 22:15:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 21:45:03 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 21:15:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 20:45:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 20:15:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 19:45:05 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 19:15:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 18:45:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 18:15:03 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 17:45:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 17:15:03 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 16:45:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 16:15:03 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 15:45:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 15:15:04 UTC -19.8007 24.6207 25000
TELESIS BIO INC TBIO 2023-03-28 14:45:03 UTC -19.8007 24.6207 20000
TELESIS BIO INC TBIO 2023-03-28 14:15:04 UTC -19.8007 24.6207 20000
TELESIS BIO INC TBIO 2023-03-28 13:45:03 UTC -17.3144 22.1344 20000
TELESIS BIO INC TBIO 2023-03-28 13:15:04 UTC -17.3144 22.1344 20000
TELESIS BIO INC TBIO 2023-03-28 12:45:04 UTC -17.3144 22.1344 30000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TBIO -900.0 shares, $-1125.0 2022-12-31 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments